Pharmacokinetics of Michellamine B, a Naphthylisoquinoline Alkaloid With in Vitro Activity Against Human Immunodeficiency Virus Types 1 and 2, in the Mouse and Dog

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.39.1.9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Induction of Neutralizing Antibodies Against Tier 2 Human Immunodeficiency Virus 1 in Rhesus Macaques Infected With Tier 1B Simian/Human Immunodeficiency Virus

Archives of Virology
MedicineVirology
2019English

In Vitro Microbicidal Activity of the Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) UC781 Against NNRTI-Resistant Human Immunodeficiency Virus Type 1

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2006English

Kinetics of Cyclophosphamide Metabolism in Human, Dog, Cat, and Mouse and Relationship to Cytotoxic Activity and Pharmacokinetics

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

Manadomanzamines a and B: A Novel Alkaloid Ring System With Potent Activity Against Mycobacteria and HIV-1.

ChemInform
2004English

Clinical Pharmacokinetics of Adefovir in Human Immunodeficiency Virus Type 1-Infected Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1995English

Activity Against Human Immunodeficiency Virus Type 1, Intracellular Metabolism, and Effects on Human DNA Polymerases of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2007English

Antiviral Activities of Glycyrrhizin and Its Modified Compounds Against Human Immunodeficiency Virus Type 1(hiv-1) and Herpes Simplex Virus Type 1(hsv-1) in Vitro.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1991English

Potencies of Human Immunodeficiency Virus Protease Inhibitors in Vitro Against Plasmodium Falciparum and in Vivo Against Murine Malaria

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Antiviral Activity of Polyoxomol Ybdoeuropate PM-104 Against Human Immunodeficiency Virus Type 1.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy